Irritable Bowel Syndrome Treatment Market Size, Share & Trends Analysis Report By Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, Others), By Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), By Distribution Channel (Hospitals pharmacies, Drug Stores and Retail Pharmacies, Online pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
  7. North America Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
  8. Europe Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
  9. APAC Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
  10. Middle East and Africa Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
  11. LATAM Irritable Bowel Syndrome Treatment Market Size Analysis
    1. Introduction
    2. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Rifaximin
      2. Eluxadoline
      3. Lubiprostone
      4. Linaclotide
      5. Others
    3. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. IBS with Diarrhea (IBS-D)
      2. IBS with Constipation (IBS-C)
      3. Mixed IBS
    4. Irritable Bowel Syndrome Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospitals pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online pharmacies
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Rifaximin
        2. Eluxadoline
        3. Lubiprostone
        4. Linaclotide
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. IBS with Diarrhea (IBS-D)
        2. IBS with Constipation (IBS-C)
        3. Mixed IBS
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals pharmacies
        2. Drug Stores and Retail Pharmacies
        3. Online pharmacies
  12. Competitive Landscape
    1. Irritable Bowel Syndrome Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Synergy Pharma
    3. Mallinckrodt
    4. Bausch Health Companies Inc.
    5. Ardelyx
    6. Astellas Pharma Inc.
    7. Novartis AG, GSK plc.
    8. Ironwood Pharmaceuticals, Inc.
    9. Takeda Pharmaceutical Company Limited.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Irritable Bowel Syndrome Treatment Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 4: Global Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 5: North America Irritable Bowel Syndrome Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 7: North America Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 8: North America Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: U.S. Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 10: U.S. Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 11: U.S. Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 12: Canada Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 13: Canada Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 14: Canada Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 15: Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 17: Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 18: Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 19: U.K. Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 20: U.K. Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 21: U.K. Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Germany Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 23: Germany Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 24: Germany Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 25: France Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 26: France Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 27: France Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Spain Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Spain Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 30: Spain Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 31: Italy Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 32: Italy Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 33: Italy Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 34: Russia Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 35: Russia Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 36: Russia Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Nordic Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 38: Nordic Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 39: Nordic Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 40: Benelux Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 41: Benelux Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 42: Benelux Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Rest of Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 44: Rest of Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 45: Rest of Europe Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 46: APAC Irritable Bowel Syndrome Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 48: APAC Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 49: APAC Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 50: China Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 51: China Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 52: China Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 53: Korea Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 54: Korea Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 55: Korea Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Japan Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Japan Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 58: Japan Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 59: India Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 60: India Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 61: India Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Australia Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 63: Australia Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 64: Australia Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 65: Singapore Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 66: Singapore Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 67: Singapore Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: Taiwan Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 69: Taiwan Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 70: Taiwan Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: South East Asia Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 72: South East Asia Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 73: South East Asia Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 74: Rest of Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 75: Rest of Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 76: Rest of Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 78: Middle East and Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 79: Middle East and Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 80: Middle East and Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: UAE Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: UAE Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 83: UAE Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 84: Turkey Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 85: Turkey Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 86: Turkey Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 87: Saudi Arabia Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 88: Saudi Arabia Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 89: Saudi Arabia Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 90: South Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 91: South Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 92: South Africa Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 93: Egypt Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 94: Egypt Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 95: Egypt Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 96: Nigeria Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 97: Nigeria Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 98: Nigeria Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 99: Rest of MEA Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 100: Rest of MEA Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 101: Rest of MEA Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 102: LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 103: LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 104: LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 105: LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 106: Brazil Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 107: Brazil Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 108: Brazil Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 109: Mexico Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 110: Mexico Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 111: Mexico Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 112: Argentina Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 113: Argentina Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 114: Argentina Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 115: Chile Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 116: Chile Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 117: Chile Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 118: Colombia Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 119: Colombia Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 120: Colombia Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 121: Rest of LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 122: Rest of LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 123: Rest of LATAM Irritable Bowel Syndrome Treatment Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: